121 related articles for article (PubMed ID: 26392778)
1. The expression and clinical significance of HDGF in osteosarcoma.
Chen Z; Qiu S; Lu X
Onco Targets Ther; 2015; 8():2509-17. PubMed ID: 26392778
[TBL] [Abstract][Full Text] [Related]
2. Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer.
Liu XJ; Liu WL; Yang FM; Yang XQ; Lu XF
Onco Targets Ther; 2015; 8():2101-9. PubMed ID: 26316779
[TBL] [Abstract][Full Text] [Related]
3. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
[TBL] [Abstract][Full Text] [Related]
4. Hepatoma-Derived Growth Factor and DDX5 Promote Carcinogenesis and Progression of Endometrial Cancer by Activating β-Catenin.
Liu C; Wang L; Jiang Q; Zhang J; Zhu L; Lin L; Jiang H; Lin D; Xiao Y; Fang W; Guo S
Front Oncol; 2019; 9():211. PubMed ID: 31032220
[No Abstract] [Full Text] [Related]
5. Upregulation of miR‑95-3p inhibits growth of osteosarcoma by targeting HDGF.
Liu X; Ma W; Ma J; Xiao L; Hao D
Pathol Res Pract; 2019 Aug; 215(8):152492. PubMed ID: 31257090
[TBL] [Abstract][Full Text] [Related]
6. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
7. Novel HDGF/HIF-1α/VEGF axis in oral cancer impacts disease prognosis.
Lin YW; Huang ST; Wu JC; Chu TH; Huang SC; Lee CC; Tai MH
BMC Cancer; 2019 Nov; 19(1):1083. PubMed ID: 31711427
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer.
Chen X; Yun J; Fei F; Yi J; Tian R; Li S; Gan X
Pathol Res Pract; 2012 Aug; 208(8):437-43. PubMed ID: 22682760
[TBL] [Abstract][Full Text] [Related]
9. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells.
Tsang TY; Tang WY; Tsang WP; Co NN; Kong SK; Kwok TT
Cell Physiol Biochem; 2009; 24(3-4):253-62. PubMed ID: 19710540
[TBL] [Abstract][Full Text] [Related]
11. p53 and hepatoma-derived growth factor expression and their clinicopathological association with Ewing family tumour.
Yang Y; Zhen T; Zhang F; Dai S; Kang L; Liang Y; Xue L; Han A
J Clin Pathol; 2014 Mar; 67(3):235-42. PubMed ID: 24072730
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma.
Wang S; Fang W
Histopathology; 2011 Jan; 58(2):217-24. PubMed ID: 21255068
[TBL] [Abstract][Full Text] [Related]
13. The expression and prognostic significance of hepatoma-derived growth factor in oral cancer.
Lin YW; Li CF; Chen HY; Yen CY; Lin LC; Huang CC; Huang HY; Wu PC; Chen CH; Chen SC; Tai MH
Oral Oncol; 2012 Jul; 48(7):629-35. PubMed ID: 22361040
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY
J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005
[TBL] [Abstract][Full Text] [Related]
15. Hepatoma-derived growth factor: A survival-related protein in prostate oncogenesis and a potential target for vitamin K2.
Shetty A; Dasari S; Banerjee S; Gheewala T; Zheng G; Chen A; Kajdacsy-Balla A; Bosland MC; Munirathinam G
Urol Oncol; 2016 Nov; 34(11):483.e1-483.e8. PubMed ID: 27692835
[TBL] [Abstract][Full Text] [Related]
16. The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome.
Li SZ; Zhao YB; Cao WD; Qu Y; Luo P; Zhen HN; Chen XY; Yan ZF; Fei Z
Med Oncol; 2013; 30(3):622. PubMed ID: 23771798
[TBL] [Abstract][Full Text] [Related]
17. Hepatoma-derived growth factor enhances osteoblastic transformation of rat aortic vascular smooth muscle cells in vitro.
Cheng CI; Chang HR; Tai MH; Chou MH; Chen GT; Chen PH; Kao YH
Life Sci; 2020 Sep; 256():117964. PubMed ID: 32534036
[TBL] [Abstract][Full Text] [Related]
18. Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Morii E; Yasuda T; Doki Y; Aozasa K; Uyama H; Nakamura H; Monden M
Ann Surg Oncol; 2007 Jul; 14(7):2141-9. PubMed ID: 17473954
[TBL] [Abstract][Full Text] [Related]
19. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors.
Hu TH; Lin JW; Chen HH; Liu LF; Chuah SK; Tai MH
Dis Colon Rectum; 2009 Feb; 52(2):319-26. PubMed ID: 19279430
[TBL] [Abstract][Full Text] [Related]
20. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
